MedTrace Logo

Vaginal Estriol Before and Vaginal Surgery for Prolapse

NCT02906111 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2016-09-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether the vaginal estriol before vaginal surgery for pelvic statics disorders is more efficacy of no estriol treatment on vaginal health and quality of life.

Conditions

  • Genital Prolapse

Interventions

DRUG

estriol

Study Group, treated with estriol Control Group, no drug treatment Both groups will undergo vaginal surgery for prolapse

PROCEDURE

vaginal surgery

Control Group

Sponsors & Collaborators

  • Salvatore Caruso

    lead OTHER

Principal Investigators

  • Antonio Cianci, Prof · Policlinico Catania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
56 Years
Max Age
63 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02906111 on ClinicalTrials.gov